m7GpppGpG
m7GpppGpG is an unmodified trinucleotide cap analog with enhancer activity. When incorporated into mRNA, it effectively enhances translational efficiency, stability, and protein expression levels of the mRNA. m7GpppGpG can serve as a standard cap analog for in vitro mRNA synthesis to support antigen generation and presentation by dendritic cells, although its expression efficiency in dendritic cells is 20-fold lower than that of the m7GpppApG cap.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 133608-76-1
- Formule: C31H41N15O25P4
- Masse moléculaire:1147.64
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Voir tous les produits spécifiques à Isoform DNA/RNA Synthesis
More
Activité biologique
m7GpppGpG (10 mM; 2 total hours at 37°C) generates the functional m7GpppGpG cap structure alongside non-functional reversed-capped molecules during in vitro mRNA synthesis, with overall capping efficiency of ~90% under typical conditions[1].
mRNA capped with m7GpppGpG exhibits 20-fold lower translation efficiency in JAWSII murine dendritic cells relative to mRNA capped with m7GpppApG, independent of eIF4E affinity and decapping enzyme resistance[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 133608-76-1
-
Masse moléculaire 1147.64
-
Formule C31H41N15O25P4
-
SMILES
O=P(O)(OC[C@@H]1[C@@H](OP(O)(OC[C@H]2O[C@@H](N3C(NC(N)=NC4=O)=C4N=C3)[C@H](O)[C@@H]2O)=O)[C@@H](O)[C@H](N5C(NC(N)=NC6=O)=C6N=C5)O1)OP(OP(OC[C@H]7O[C@@H](N8C(NC(N)=N9)=C([N+](C)=C8)C9=O)[C@H](O)[C@@H]7O)([O-])=O)(O)=O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Grudzien-Nogalska E, et al. Synthetic mRNAs with superior translation and stability properties. Methods in molecular biology (Clifton, N.J.). 2013;969:55-72. [Content Brief]
[2]. Uchida S, et al. Nanomedicine-Based Approaches for mRNA Delivery. Molecular pharmaceutics. 2020 Oct 05;17(10):3654-3684. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)